Correlation of C-Reactive Protein (CRP) levels with disease activity in chronic urticaria measured by Urticaria Activity Score-7 (UAS7)

Authors

  • Marsha Bianti Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
  • Sondang P Sirait Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
  • Herqutanto Department of Community Medicine, Faculty of Medicine, Universitas Indonesia
  • Sandra Widaty Department of Dermatology and Venereologi Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunsukumo Hospital, Indonesia

DOI:

https://doi.org/10.66344/jpad.v32i2.1874

Keywords:

Biomarker, chronic urticaria

Abstract

Background  The Urticaria Activity Score-7 (UAS7) questionnaire is used to assess clinical disease activity in chronic urticaria (CU). The questionnaire is subjective in nature, thus several reports suggest that an objective parameter, such as C-reactive protein (CRP), is needed to support disease activity assessment in CU.

 

Objective To investigate the relationship between CRP levels and clinical disease activity assessed using UAS7 in patients with CU.

 

Methods Our study was a quasi-experimental study, using the one group pretest-post test design. We recruited 18 patients aged 18-59 years old with CU who met inclusion and exclusion criteria. We assessed disease activity using the UAS7 questionnaire and measured CRP levels at the first visit. All subjects received an antihistamine (10 mg cetirizine) for 4 weeks and follow-up levels were measured post-treatment. Disease activity was assessed in weekly follow-ups using UAS7. Spearman analysis was used to calculate the correlation between CRP levels and disease activity.

 

Results We found an increase in CRP levels in more than a third of subjects (median 2.5 mg/L [range 0.1-8.7 mg/L]). Prior to antihistamine treatment, the median UAS7 score was 14 (range 5-32), and the median UAS7 score in the first to fourth week of treatment was 3 (range 0-14), 4 (range 0-14), 3 (range 0-14), and 2 (range 0-12), respectively. The relationship was statistically significant, with a coefficient of correlation of 0.529 (p=0.024).

 

Conclusion CRP levels were increased in CU patients. CRP levels were significantly correlated with clinical disease activity measured by UAS7. After receiving antihistamines, the proportion of subjects with high CRP levels decreased.

 

 

References

1. Hide M, Takahagi S, Hiragun T. Urticaria and angioedema. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., eds. Fitzpatrick’s Dermatology in General Medicine. 9th ed. New York: Mc Graw Hill; 2019. p.684-709.

2. Powell RJ, Leech SC, Huber PAJ, Nasser SM, Clark AT. BSACI guideline for the management of chronic urticarial and angioedema. Clin Exp Allergy. 2015;45:547-65.

3. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: The 2017 revision and update. Allergy. 2018;73:1393-1414.

4. Department of Dermatology and Venereology, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital. Allergy-Immunology Division Patient Registry. Jakarta; 2019 (Unpublished).

5. Wardhana M. Suryawati N, Ariana. The effect of psychological stress on c-reactive protein and peripheral blood cells count in chronic idiopathic urticaria. Bali Med J. 2017;6(1):198-203.

6. Sproston NR, Ashworth JJ. Role of C-Reactive Protein at sites of inflammation and infection. Front Immunol. 2018;9:754.

7. Faraschian M, Ansar A, Sobhan M, Hoseinpoor V. C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B. An Bras Dermatol. 2016;91:580-3.

8. Kolkhir P, Andre F, Church MK, Maurer M, Metz M. Potential blood biomarkers in chronic spontaneous urticarial. Clin Exp Allergy. 2017;47:19-36.

9. Kolkhir P, Altrichter S, Hawro T, Maurer M. CRP is linked to disease activity, impact and response to treatment in patients with chronic spontaneous urticaria. Allergy. 2018;73:940-8.

10. Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Kameyoshi Y, et al. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy. 2010;65(5):649-56.

11. Kasperska-Zajac A, Sztyle J, Machura E, Jop G. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy. 2011;41:1386-91.

12. Maouia A, Youssef M, Leban N, Ben Chibani J, Helal AN, Kassab A. CRP relevance in clinical assessment of chronic spontaneous urticarial Tunisian patients. Cutan Ocul Toxicol. 2017;36:387-92.

13. Baek YS, Jeon J, Kim JH, Oh CH. Severity of acute and chronic urticarial correlates with D-dimer level, but not C-reactive protein or total IgE. Clin Exp Dermatol. 2014;39:795-800.

Downloads

Published

01.06.2022

Issue

Section

Original Articles

How to Cite

1.
Correlation of C-Reactive Protein (CRP) levels with disease activity in chronic urticaria measured by Urticaria Activity Score-7 (UAS7). J Pak Assoc Dermatol [Internet]. 2022 Jun. 1 [cited 2026 Sep. 6];32(2):248-54. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1874